Skip to content

Commit

Permalink
Merge pull request #908 from ScilifelabDataCentre/develop
Browse files Browse the repository at this point in the history
Update W44
  • Loading branch information
senthil10 authored Nov 3, 2022
2 parents 00b04ec + d97a3e5 commit a438d1e
Show file tree
Hide file tree
Showing 10 changed files with 319 additions and 49 deletions.
7 changes: 4 additions & 3 deletions Dockerfiles/Dockerfile
Original file line number Diff line number Diff line change
@@ -1,5 +1,6 @@
FROM klakegg/hugo:0.91.2-onbuild AS build
FROM klakegg/hugo:0.104.3-ubuntu-onbuild AS build

FROM nginx:alpine
COPY Dockerfiles/default.conf /etc/nginx/conf.d/default.conf
FROM nginxinc/nginx-unprivileged:alpine
COPY --from=build /target /usr/share/nginx/html

EXPOSE 8080
31 changes: 0 additions & 31 deletions Dockerfiles/default.conf

This file was deleted.

1 change: 0 additions & 1 deletion content/english/dashboards/_index.md
Original file line number Diff line number Diff line change
Expand Up @@ -122,4 +122,3 @@ CSSS continuously collects data on COVID-19 prevalence, symptoms, and vaccinatio

<script src="https://datagraphics.dckube.scilifelab.se/graphic/e4c6a7b8bff648a5adaabbdd3d994bf9.js?id=serology"></script>
<script src="https://datagraphics.dckube.scilifelab.se/graphic/93bad55e86ad4b0f97d4d27c77862bc9.js?id=stockholm_wastewater"></script>
<script src="https://datagraphics.dckube.scilifelab.se/graphic/530ca62cc6f7449680793a252155fee3.js?id=postcovid_halthcare_contacts"></script>
6 changes: 1 addition & 5 deletions content/english/resources/rapid_type_variants.md
Original file line number Diff line number Diff line change
Expand Up @@ -12,8 +12,4 @@ for_background_table:
lab: Uppsala University Hospital
---

During the recent SARS-CoV-2 pandemic it has been evident that a swift response relies on the capacity to quickly establish methodologies for clinical diagnostics and epidemiologic surveillance.Whereas the first generation of commercial kits were sold as Research Use Only, had low capacity and often characterized by poor performance, robust methodologies were despite tremendous effort from the manufacturers and frequent use of Emergency Use labeling by regulatory agencies not available until the first wave was almost over.

When the virus variants of concern (VOCs) emerged, it was clear that ambitious sequencing programs, although remarkably impressive and invaluable for generation of big data, nevertheless were insufficient in terms of capacity and sensitivity and were inherently too slow for clinical usage. Instead, first line surveillance had to be accomplished by simpler methods that focused on critical sites for defining polymorphism rather than whole genome sequencing.

From spring 2021 to summer 2022, we have typed almost all positive samples and monitored the emergence of different VOCs including B.1.1.7/Alpha, B.617.2/Delta, as well as the Omicron variants BA.1, BA.2 and BA.5. While the resolution is lower, the sensitivity is higher and its focus on relevant mutations mostly provides sufficient information to correctly identify the VOCs. For contact tracing and for clinical decisions regarding type-specific therapy, rapid typing was far superior compared to whole genome sequencing. In this project, we will develop a generalized platform based on focused sequencing techniques combined with serological testing that can be used for rapid detection and characterization of emerging variants of any etiologic agent.
Throughout the recent SARS-CoV-2 pandemic, it has been evident that a swift response relies on the capacity to quickly establish methodologies for clinical diagnostics and epidemiologic surveillance. The first generation of commercial kits were sold as "Research Use Only", had low capacity, and were often characterised by poor performance. Robust methodologies were, despite tremendous effort from the manufacturers and the frequent use of "Emergency Use" labelling by regulatory agencies, not available until the first wave was almost over. When the virus variants of concern (VOCs) emerged, it was clear that ambitious sequencing programs, although remarkably impressive and invaluable for the generation of big data, were nevertheless insufficient in terms of capacity and sensitivity, and were inherently too slow for clinical usage. Instead, first line surveillance had to be accomplished by simpler methods that focused on critical sites for defining polymorphism, rather than whole genome sequencing. From spring 2021 to summer 2022, we have typed almost all positive samples and monitored the emergence of different VOCs, including B.1.1.7/Alpha, B.617.2/Delta, as well as the Omicron variants BA.1, BA.2 and BA.5. Whilst the resolution is lower, the sensitivity is higher and its focus on relevant mutations mostly provides sufficient information to correctly identify the VOCs. For both contact tracing and clinical decisions regarding type-specific therapy, rapid typing was far superior compared to whole genome sequencing. In this project, we will develop a generalised platform based on focused sequencing techniques combined with serological testing that can be used for the rapid detection and characterisation of emerging variants of any etiologic agent.
1 change: 0 additions & 1 deletion content/svenska/dashboards/_index.md
Original file line number Diff line number Diff line change
Expand Up @@ -110,4 +110,3 @@ CSSS samlar kontinuerligt in data om Covid-19 förekomste, symptom, och vaccinat

<script src="https://datagraphics.dckube.scilifelab.se/graphic/e4c6a7b8bff648a5adaabbdd3d994bf9.js?id=serology"></script>
<script src="https://datagraphics.dckube.scilifelab.se/graphic/93bad55e86ad4b0f97d4d27c77862bc9.js?id=stockholm_wastewater"></script>
<script src="https://datagraphics.dckube.scilifelab.se/graphic/530ca62cc6f7449680793a252155fee3.js?id=postcovid_halthcare_contacts"></script>
273 changes: 272 additions & 1 deletion data/available_datasets.json
Original file line number Diff line number Diff line change
@@ -1,6 +1,277 @@
{
"last_updated": "2022-10-07",
"last_updated": "2022-11-03",
"datasets": [
{
"doi": "10.3389/fpubh.2022.996036",
"available_items": [
{
"type": "data",
"repo_name": "OSF",
"accession_number": "",
"description": "Data for collectivism and mobility",
"data_type": [
"Other data"
],
"data_url": "https://osf.io/xt5qs/?view_only=e7da6b6f69f24bc7b3a9656d00cebb10"
}
],
"title": "Collectivism reduces objective mobility trends to public areas during the COVID-19 pandemic",
"issue": "",
"volume": "10",
"publisher": "Frontiers Media SA",
"published": "2022-09-28",
"author": [
"Dang J.",
"Xiao S."
]
},
{
"doi": "10.1038/s41380-022-01786-2",
"available_items": [
{
"type": "code",
"repo_name": "GitHub",
"accession_number": "",
"description": "Source code to reproduce the findings",
"data_type": [
"Genomics & transcriptomics data"
],
"data_url": "https://github.com/SellgrenLab/organoid-Covid19"
}
],
"title": "SARS-CoV-2 promotes microglial synapse elimination in human brain organoids",
"issue": "",
"volume": "",
"publisher": "Springer Science and Business Media LLC",
"published": "2022-10-05",
"author": [
"Samudyata S.",
"Oliveira A. O.",
"Malwade S.",
"Rufino de Sousa N.",
"Goparaju S. K."
]
},
{
"doi": "10.1371/journal.pone.0275380",
"available_items": [
{
"type": "protocol",
"repo_name": "OSF",
"accession_number": "",
"description": "The protocol for this study",
"data_type": [
"Other data"
],
"data_url": "https://osf.io/jgwvk/"
},
{
"type": "code",
"repo_name": "GitHub",
"accession_number": "",
"description": "Code and data",
"data_type": [
"Other data"
],
"data_url": "https://github.com/zavalis/transparency-indicators-inf-dis-models"
}
],
"title": "A meta-epidemiological assessment of transparency indicators of infectious disease models",
"issue": "10",
"volume": "17",
"publisher": "Public Library of Science (PLoS)",
"published": "2022-10-07",
"author": [
"Zavalis E. A.",
"Ioannidis J. P. A."
]
},
{
"doi": "",
"available_items": [
{
"type": "",
"repo_name": "",
"accession_number": "",
"description": "",
"data_type": [],
"data_url": ""
}
],
"title": "",
"issue": "",
"volume": "",
"publisher": "",
"published": "",
"author": []
},
{
"doi": "10.1038/s41598-022-17303-y",
"available_items": [
{
"type": "data",
"repo_name": "OSF",
"accession_number": "",
"description": "Processed and anonymized data that support the findings of this study",
"data_type": [
"Other data"
],
"data_url": "https://osf.io/vr6p4/?view_only=070d364b489b43fca34bfcfd811ed22b"
}
],
"title": "Development and cross-national investigation of a model explaining participation in WHO-recommended and placebo behaviours to prevent COVID-19 infection",
"issue": "1",
"volume": "12",
"publisher": "Springer Science and Business Media LLC",
"published": "2022-10-21",
"author": [
"Kłosowska J.",
"Bajcar E. A.",
"Bieniek H.",
"Brączyk J.",
"Joshanloo M."
]
},
{
"doi": "10.1016/j.evolhumbehav.2022.09.003",
"available_items": [
{
"type": "data",
"repo_name": "OSF",
"accession_number": "",
"description": "Associated data",
"data_type": [
"Other data"
],
"data_url": "https://osf.io/p9z2a/"
}
],
"title": "Family still matters: Human social motivation across 42 countries during a global pandemic",
"issue": "6",
"volume": "43",
"publisher": "Elsevier BV",
"published": "2022-11-02",
"author": [
"Pick C. M.",
"Ko A.",
"Wormley A. S.",
"Wiezel A.",
"Kenrick D. T."
]
},
{
"doi": "10.1038/s41598-022-22711-1",
"available_items": [
{
"type": "data",
"repo_name": "MR-base",
"accession_number": "ebi-a-GCST005536",
"description": "Type 1 diabetes mellitus",
"data_type": [
"Other data"
],
"data_url": "https://gwas.mrcieu.ac.uk/datasets/ebi-a-GCST005536"
},
{
"type": "data",
"repo_name": "MR-base",
"accession_number": "ebi-a-GCST003156",
"description": "Systemic lupus erythematosus",
"data_type": [
"Other data"
],
"data_url": "https://gwas.mrcieu.ac.uk/datasets/ebi-a-GCST003156"
},
{
"type": "data",
"repo_name": "MR-base",
"accession_number": "ebi-a-GCST005527",
"description": "Psoriasis",
"data_type": [
"Other data"
],
"data_url": "https://gwas.mrcieu.ac.uk/datasets/ebi-a-GCST005527"
},
{
"type": "data",
"repo_name": "MR-base",
"accession_number": "ieu-b-18",
"description": "Multiple sclerosis",
"data_type": [
"Other data"
],
"data_url": "https://gwas.mrcieu.ac.uk/datasets/ieu-b-18"
},
{
"type": "data",
"repo_name": "MR-base",
"accession_number": "ieu-a-1112",
"description": "Primary sclerosing cholangitis",
"data_type": [
"Other data"
],
"data_url": "https://gwas.mrcieu.ac.uk/datasets/ieu-a-1112"
},
{
"type": "data",
"repo_name": "MR-base",
"accession_number": "ebi-a-GCST005581",
"description": "Primary biliary cirrhosis",
"data_type": [
"Other data"
],
"data_url": "https://gwas.mrcieu.ac.uk/datasets/ebi-a-GCST005581"
},
{
"type": "data",
"repo_name": "OSF",
"accession_number": "",
"description": "Datasets analyzed",
"data_type": [
"Other data"
],
"data_url": "https://osf.io/sxjyc/"
}
],
"title": "A Mendelian randomization study of genetic predisposition to autoimmune diseases and COVID-19",
"issue": "1",
"volume": "12",
"publisher": "Springer Science and Business Media LLC",
"published": "2022-10-21",
"author": [
"Li S.",
"Yuan S.",
"Schooling C. M.",
"Larsson S. C."
]
},
{
"doi": "10.1101/2022.10.06.22280777",
"available_items": [
{
"type": "data",
"repo_name": "OSF",
"accession_number": "",
"description": "Anonymised databases with the individual participant data and the metadata for Bayesian analyses, with analytical code",
"data_type": [
"Other data"
],
"data_url": "https://osf.io/2xn5m/"
}
],
"title": "Treating intrusive memories after trauma in healthcare workers: a Bayesian adaptive randomised trial developing an imagery-competing task intervention",
"issue": "",
"volume": "",
"publisher": "Cold Spring Harbor Laboratory",
"published": "2022-10-07",
"author": [
"Ramineni V.",
"Millroth P.",
"Iyadurai L.",
"Jaki T.",
"Kingslake J."
]
},
{
"doi": "10.15252/emmm.202215821",
"available_items": [
Expand Down
17 changes: 16 additions & 1 deletion data/funding.json
Original file line number Diff line number Diff line change
@@ -1,6 +1,21 @@
{
"last_updated": "2022-09-30",
"last_updated": "2022-11-01",
"calls": [
{
"topic": [
"Infectious diseases",
"General"
],
"funder": "Hedlunds Stifelse",
"call_title": "Medical Research",
"call_url": "http://www.hedlundsstiftelse.se/ansokan/default_eng.htm",
"call_description": "The overall objective of the call is to support research related to brain diseases (including psychiatry), infectious disease, and chronic inflammatory diseases.",
"submission_deadline": "2023-01-31",
"submission_opendate": "2022-11-01",
"applicant": "A PhD researcher at a Swedish University/college conducting qualified medical research. The funds are paid out to the University/college.",
"funding_period": "Applications are approved one year at a time for a maximum of 3 years.",
"decision_date": "Following board meeting in April/May 2023."
},
{
"topic": [
"COVID-19",
Expand Down
2 changes: 1 addition & 1 deletion data/publications.json

Large diffs are not rendered by default.

Loading

0 comments on commit a438d1e

Please sign in to comment.